Targeting SR Proteins Improves SMN Expression in Spinal Muscular Atrophy Cells

Spinal muscular atrophy (SMA) is one of the most common inherited causes of pediatric mortality. SMA is caused by deletions or mutations in the survival of motor neuron 1 (SMN1) gene, which results in SMN protein deficiency. Humans have a centromeric copy of the survival of motor neuron gene, SMN2, which is nearly identical to SMN1. However, SMN2 cannot compensate for the loss of SMN1 because SMN2 has a single-nucleotide difference in exon 7, which negatively affects splicing of the exon. As a result, most mRNA produced from SMN2 lacks exon 7. SMN2 mRNA lacking exon 7 encodes a truncated protein with reduced functionality. Improving SMN2 exon 7 inclusion is a goal of many SMA therapeutic strategies. The identification of regulators of exon 7 inclusion may provide additional therapeutic targets or improve the design of existing strategies. Although a number of regulators of exon 7 inclusion have been identified, the function of most splicing proteins in exon 7 inclusion is unknown. Here, we test the role of SR proteins and hnRNP proteins in SMN2 exon 7 inclusion. Knockdown and overexpression studies reveal that SRSF1, SRSF2, SRSF3, SRSF4, SRSF5, SRSF6, SRSF7, SRSF11, hnRNPA1/B1 and hnRNP U can inhibit exon 7 inclusion. Depletion of two of the most potent inhibitors of exon 7 inclusion, SRSF2 or SRSF3, in cell lines derived from SMA patients, increased SMN2 exon 7 inclusion and SMN protein. Our results identify novel regulators of SMN2 exon 7 inclusion, revealing potential targets for SMA therapeutics.

[1]  Ahmed S. Moursy,et al.  Characterization of the RNA recognition mode of hnRNP G extends its role in SMN2 splicing regulation , 2014, Nucleic acids research.

[2]  A. Krainer,et al.  Role of the Modular Domains of SR Proteins in Subnuclear Localization and Alternative Splicing Specificity , 1997, The Journal of cell biology.

[3]  Henning Urlaub,et al.  Small Nuclear Ribonucleoprotein Remodeling During Catalytic Activation of the Spliceosome , 2002, Science.

[4]  James A. Thomson,et al.  Induced pluripotent stem cells from a spinal muscular atrophy patient , 2009, Nature.

[5]  Michael R. Green,et al.  PSF contacts exon 7 of SMN2 pre-mRNA to promote exon 7 inclusion. , 2014, Biochimica et biophysica acta.

[6]  E. Fisher,et al.  Faculty Opinions recommendation of Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model. , 2011 .

[7]  B. Wirth,et al.  Deficiency of the splicing factor Sfrs10 results in early embryonic lethality in mice and has no impact on full-length SMN/Smn splicing. , 2010, Human molecular genetics.

[8]  Y. Hua,et al.  Synthetic oligonucleotides recruit ILF2/3 to RNA transcripts to modulate splicing. , 2012, Nature chemical biology.

[9]  S. Stamm,et al.  The splicing regulator Sam68 binds to a novel exonic splicing silencer and functions in SMN2 alternative splicing in spinal muscular atrophy , 2010, The EMBO journal.

[10]  Xiang-Dong Fu,et al.  Nuclear matrix factor hnRNP U/SAF-A exerts a global control of alternative splicing by regulating U2 snRNP maturation. , 2012, Molecular cell.

[11]  B. Dallapiccola,et al.  Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients. , 1995, Biochemical and biophysical research communications.

[12]  A. Zahler,et al.  Distinct functions of SR proteins in alternative pre-mRNA splicing. , 1993, Science.

[13]  A. Hartmann,et al.  Heterogeneous Nuclear Ribonucleoprotein G Regulates Splice Site Selection by Binding to CC(A/C)-rich Regions in Pre-mRNA* , 2009, Journal of Biological Chemistry.

[14]  Jan-Gowth Chang,et al.  5‐(N‐ethyl‐N‐isopropyl)‐amiloride enhances SMN2 exon 7 inclusion and protein expression in spinal muscular atrophy cells , 2008, Annals of neurology.

[15]  Y. Hofmann,et al.  hnRNP-G promotes exon 7 inclusion of survival motor neuron (SMN) via direct interaction with Htra2-beta1. , 2002, Human molecular genetics.

[16]  Nikolaus Grigorieff,et al.  Purification and characterization of native spliceosomes suitable for three-dimensional structural analysis. , 2002, RNA.

[17]  J. McPherson,et al.  A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. , 1999, Human molecular genetics.

[18]  Yael Mandel-Gutfreund,et al.  RBPmap: a web server for mapping binding sites of RNA-binding proteins , 2014, Nucleic Acids Res..

[19]  S. Stamm,et al.  Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2). , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. Burghes,et al.  Antisense oligonucleotides for the treatment of spinal muscular atrophy. , 2013, Human gene therapy.

[21]  A. Krainer,et al.  Substrate Specificities of SR Proteins in Constitutive Splicing Are Determined by Their RNA Recognition Motifs and Composite Pre-mRNA Exonic Elements , 1999, Molecular and Cellular Biology.

[22]  J. Manley,et al.  An intronic element contributes to splicing repression in spinal muscular atrophy , 2007, Proceedings of the National Academy of Sciences.

[23]  C. Lorson,et al.  Delivery of bifunctional RNAs that target an intronic repressor and increase SMN levels in an animal model of spinal muscular atrophy. , 2009, Human molecular genetics.

[24]  Hung Li,et al.  Analysis of the mRNA transcripts of the survival motor neuron (SMN) gene in the tissue of an SMA fetus and the peripheral blood mononuclear cells of normals, carriers and SMA patients , 2000, Journal of the Neurological Sciences.

[25]  Jinhua Wang,et al.  ESEfinder: a web resource to identify exonic splicing enhancers , 2003, Nucleic Acids Res..

[26]  T. Wienker,et al.  Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. , 2002, American journal of human genetics.

[27]  D. Pearl,et al.  Newborn and carrier screening for spinal muscular atrophy , 2010, American journal of medical genetics. Part A.

[28]  K. Imaizumi,et al.  An Intronic Splicing Enhancer Element in Survival Motor Neuron (SMN) Pre-mRNA* , 2003, The Journal of Biological Chemistry.

[29]  C. Lorson,et al.  Morpholino antisense oligonucleotides targeting intronic repressor Element1 improve phenotype in SMA mouse models. , 2014, Human molecular genetics.

[30]  M. Wilm,et al.  A subset of human 35S U5 proteins, including Prp19, function prior to catalytic step 1 of splicing , 2004, The EMBO journal.

[31]  J. Manley,et al.  A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy , 2003, Nature Genetics.

[32]  Henning Urlaub,et al.  Protein Composition and Electron Microscopy Structure of Affinity-Purified Human Spliceosomal B Complexes Isolated under Physiological Conditions , 2006, Molecular and Cellular Biology.

[33]  J. Manley,et al.  A protein factor, ASF, controls cell-specific alternative splicing of SV40 early pre-mRNA in vitro , 1990, Cell.

[34]  D. Black.  Mechanisms of alternative pre-messenger RNA splicing. , 2003, Annual review of biochemistry.

[35]  J. Cáceres,et al.  The SR protein family of splicing factors: master regulators of gene expression. , 2009, The Biochemical journal.

[36]  A. Ebert,et al.  A feedback loop regulates splicing of the spinal muscular atrophy-modifying gene, SMN2 , 2010, Human molecular genetics.

[37]  Faraz Farooq,et al.  p38 Mitogen-activated protein kinase stabilizes SMN mRNA through RNA binding protein HuR. , 2009, Human molecular genetics.

[38]  B R Franza,et al.  Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors. , 1998, RNA.

[39]  Andrew J Schwab,et al.  EZ spheres: a stable and expandable culture system for the generation of pre-rosette multipotent stem cells from human ESCs and iPSCs. , 2013, Stem cell research.

[40]  J. Manley,et al.  hnRNP A1 functions with specificity in repression of SMN2 exon 7 splicing. , 2007, Human molecular genetics.

[41]  H. Urlaub,et al.  Isolation of an active step I spliceosome and composition of its RNP core , 2008, Nature.

[42]  Jia Huang,et al.  Expression Pattern and Splicing Function of Mouse ZNF265 , 2008, Neurochemical Research.

[43]  C. DiDonato,et al.  Antisense oligonucleotide mediated therapy of spinal muscular atrophy , 2013, Translational neuroscience.

[44]  M B Roth,et al.  SR proteins: a conserved family of pre-mRNA splicing factors. , 1992, Genes & development.

[45]  Sharlene R. Lim,et al.  Modulation of Survival Motor Neuron Pre-mRNA Splicing by Inhibition of Alternative 3′ Splice Site Pairing* , 2001, The Journal of Biological Chemistry.

[46]  Xiaoming Yang,et al.  Predominant expression of exon 7 skipped SMN mRNAs in lung based on analysis of transcriptome sequencing datasets , 2014, Neurological Sciences.

[47]  A. Krainer,et al.  Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1 , 2002, Nature Genetics.

[48]  Y. Hua,et al.  Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice. , 2008, American journal of human genetics.

[49]  Jason M. Edmonds,et al.  Tetracyclines That Promote SMN2 Exon 7 Splicing as Therapeutics for Spinal Muscular Atrophy , 2009, Science Translational Medicine.

[50]  C. Lorson,et al.  SRp30c-dependent stimulation of survival motor neuron (SMN) exon 7 inclusion is facilitated by a direct interaction with hTra2 beta 1. , 2002, Human molecular genetics.

[51]  Y. Hua,et al.  Antisense Oligonucleotides Delivered to the Mouse CNS Ameliorate Symptoms of Severe Spinal Muscular Atrophy , 2011, Science Translational Medicine.

[52]  A. Krainer,et al.  Functions of SR proteins in the U12-dependent AT-AC pre-mRNA splicing pathway. , 2001, RNA.

[53]  E. Ottesen,et al.  TIA1 Prevents Skipping of a Critical Exon Associated with Spinal Muscular Atrophy , 2010, Molecular and Cellular Biology.

[54]  A. Krainer,et al.  RNA splicing specificity determined by the coordinated action of RNA recognition motifs in SR proteins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[55]  T. Bebee,et al.  Splicing regulation of the survival motor neuron genes and implications for treatment of spinal muscular atrophy. , 2010 .

[56]  A. Krainer,et al.  Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. , 1994, Science.

[57]  M. Ruggiu,et al.  A Role for SMN Exon 7 Splicing in the Selective Vulnerability of Motor Neurons in Spinal Muscular Atrophy , 2011, Molecular and Cellular Biology.

[58]  A. Krainer,et al.  The gene encoding the splicing factor SF2/ASF is a proto-oncogene , 2007, Nature Structural &Molecular Biology.

[59]  M. Wilm,et al.  Protein composition of human prespliceosomes isolated by a tobramycin affinity-selection method , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[60]  N. Barbosa-Morais,et al.  Tissue-specific splicing factor gene expression signatures , 2008, Nucleic acids research.

[61]  R. Lu,et al.  The RNA Binding Protein hnRNP Q Modulates the Utilization of Exon 7 in the Survival Motor Neuron 2 (SMN2) Gene , 2008, Molecular and Cellular Biology.

[62]  E. Ottesen,et al.  An intronic structure enabled by a long-distance interaction serves as a novel target for splicing correction in spinal muscular atrophy , 2013, Nucleic acids research.

[63]  C. Lorson,et al.  A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[64]  Natalia N Singh,et al.  Alternative splicing in spinal muscular atrophy underscores the role of an intron definition model , 2011, RNA biology.

[65]  S. Wilton,et al.  A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse. , 2012, Human molecular genetics.

[66]  Adrian R. Krainer,et al.  Control of Pre-mRNA Splicing by the General Splicing Factors PUF60 and U2AF65 , 2007, PloS one.

[67]  J. Manley,et al.  Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways. , 1995, RNA.

[68]  Arnold Munnich,et al.  Correlation between severity and SMN protein level in spinal muscular atrophy , 1997, Nature Genetics.

[69]  E. Sakashita,et al.  Human RNPS1 and Its Associated Factors: a Versatile Alternative Pre-mRNA Splicing Regulator In Vivo , 2004, Molecular and Cellular Biology.

[70]  Gene W. Yeo,et al.  Variation in alternative splicing across human tissues , 2004, Genome Biology.

[71]  Gene W. Yeo,et al.  Genome-wide analysis reveals SR protein cooperation and competition in regulated splicing. , 2013, Molecular cell.

[72]  A. Krainer,et al.  Differential 3' splice site recognition of SMN1 and SMN2 transcripts by U2AF and U2 snRNP. , 2009, RNA.

[73]  J. Weissenbach,et al.  Identification and characterization of a spinal muscular atrophy-determining gene , 1995, Cell.

[74]  Y. Hua,et al.  Antisense-based therapy for the treatment of spinal muscular atrophy , 2012, The Journal of cell biology.

[75]  L. Tranchevent,et al.  Endothelial, epithelial, and fibroblast cells exhibit specific splicing programs independently of their tissue of origin , 2014, Genome research.

[76]  Henning Urlaub,et al.  Composition and three‐dimensional EM structure of double affinity‐purified, human prespliceosomal A complexes , 2007, The EMBO journal.

[77]  Elisa de Stanchina,et al.  Determinants of exon 7 splicing in the spinal muscular atrophy genes, SMN1 and SMN2. , 2006, American journal of human genetics.

[78]  A. Krainer,et al.  A specific subset of SR proteins shuttles continuously between the nucleus and the cytoplasm. , 1998, Genes & development.

[79]  B. Wirth,et al.  The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cells , 2006, Human Genetics.

[80]  L. D. Schroeder,et al.  SMN2 exon 7 splicing is inhibited by binding of hnRNP A1 to a common ESS motif that spans the 3′ splice site , 2011, Human mutation.

[81]  T. Maniatis,et al.  The 35-kDa mammalian splicing factor SC35 mediates specific interactions between U1 and U2 small nuclear ribonucleoprotein particles at the 3' splice site. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[82]  Gunadi,et al.  HnRNP C1/C2 may regulate exon 7 splicing in the spinal muscular atrophy gene SMN1. , 2008, The Kobe journal of medical sciences.

[83]  Adrian R. Krainer,et al.  The essential pre-mRNA splicing factor SF2 influences 5′ splice site selection by activating proximal sites , 1990, Cell.

[84]  A. Krainer,et al.  A rational nomenclature for serine/arginine-rich protein splicing factors (SR proteins). , 2010, Genes & development.

[85]  Tom Maniatis,et al.  Selection and Characterization of Pre-mRNA Splicing Enhancers: Identification of Novel SR Protein-Specific Enhancer Sequences , 1999, Molecular and Cellular Biology.

[86]  K. Imaizumi,et al.  Identification of a Cis-acting Element for the Regulation ofSMN Exon 7 Splicing* , 2002, The Journal of Biological Chemistry.

[87]  I-Fan Wang,et al.  TDP-43 Overexpression Enhances Exon 7 Inclusion during the Survival of Motor Neuron Pre-mRNA Splicing* , 2008, Journal of Biological Chemistry.

[88]  N. Gilbert,et al.  SMN gene duplication and the emergence of the SMN2 gene occurred in distinct hominids: SMN2 is unique to Homo sapiens , 2001, Human Genetics.